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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S377ECGs and vital signs were unremarkable and similar across all treat-
ments. Plasma TCA concentration across the FX006 doseswere linear and
dose-dependent. Peak plasma concentrations achieved with 40 mg TCA
IR were 10X of those seen with FX006 40 mg.
Conclusions: It is demonstrated that sustained residency of TCA in the
joint prolongs therapeutic effect. The 40 mg dose of FX006 produced an
effect atWeek 12 (3.7) that was equivalent to the maximal effect of TCA
IR at Week 4. Surprisingly, between Weeks 2 and 11, the analgesic effect
of the 40mg dose of FX006 exceeded themaximal effect of TCA IR seen at
Week 4. This observation suggests that prolonged occupation of the
corticosteroid receptor may be associated with an enhanced analgesic
effect. Further, this ampliﬁcation of effect may constitute a meaningful
clinical improvement relative toTCA IR as indicated by the 20% responder
analysis for the 40 mg dose of FX006. A study is underway to determine
the TCA concentrations in the joint at varying time points, and sub-
sequent studies against placebo will deﬁne effect size and duration of
action.
Figure 1. Weekly Mean of Average Daily Pain Score (ADP)
Figure 2. Proportion of Responders, >20% ImprovementTable 1
Secondary efﬁcacy endpoints at Week 8; FX006 10 mg and 40 mg vs. TCA IR.
FX006 10 mg (n ¼ 58) FX006 40 mg (n ¼ 59)
WOMAC A (pain) 0–4 Likert scale LSMD vs TCA IR (90% CI) 2 sided p-value 0.27 (0.51, 0.03) 0.0654 0.37 (0.61, 0.13) 0.0116
WOMAC A1 (pain on walking) 0–4 Likert scale LSMD vs TCA IR (90% CI) 2 sided p-value 0.3 (0.6, 0.1) 0.0490 0.4 (0.7, 0.1) 0.0196
WOMAC B (stiffness) 0–4 Likert scale LSMD vs TCA IR (90% CI) 2 sided p-value 0.38 (0.65, 0.10) 0.0252 -0.49 (0.77, 0.22) 0.0036
WOMAC C (function) 0–4 Likert scale LSMD vs TCA IR (90% CI) 2 sided p-value 0.28 (0.52, 0.0.4) 0.0518 0.37 (0.61, 0.14) 0.0098
OMERACT-OARSI Responders n(%) p-value (vs. TCA IR) 52 (91.2%) 0.0076 53 (89.8%) 0.0118
PGIC1–7 Likert scale LSMD vs TCA IR (90% CI) 2 sided p-value 0.6 (1.0, 0.2) 0.0116 0.7 (1.1, 0.3) 0.0026
CGIC1–7 Likert scale LSMO vs TCA IR (90% CI) 2 sided p-value 0.6 (1.0, 0.2) 0.0098 0.7 (1.1, 0.3) 0.0026
LSMD ¼ Least square mean difference.669
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Purpose: Knee instability is common in persons with knee osteo-
arthritis (OA). Yet, little is known regarding risk factors for knee insta-
bility and therefore the etiology and appropriate therapeutic
interventions for this problem are unclear. Perceived knee instability
may have variations in severity from actual ‘giving way’ of the knee
(“buckling”) to sensations that a knee is slipping or shifting but may not
actually give way (“slipping”). Knee instability has been found to be
associated with muscle weakness, a treatable cause, in several studies
but none have examined if weakness predicts onset or worsening of
instability. In addition, it is unknown whether decreased vibratory
sense, common in older adults, is present with knee OA, and may create
alterations in knee position sense, increasing vulnerability to instability.
Here, we evaluate the associations of muscle strength and vibratory
sense with the incidence and worsening of knee instability.
Methods: MOST is a NIH-funded longitudinal study of persons with or
at risk for symptomatic knee OA. Participant visits at 60, 72 and 84
months were used for this analysis. At the 60-month visit, participants
underwent evaluation of unilateral isokinetic knee extensor strength
and bilateral evaluation of vibratory perception threshold (VPT). VPT
was evaluated using a biothesiometer. The applicator tip was placed on
preselected anatomic bony prominences. The voltage was initially set
at “0” and then increased by 1 volt/second until the participant
acknowledged sensation and this was deﬁned as the VPT. The mean
VPT between the limbs was used for analyses. Quadriceps strength was
evaluated as the maximum torque during active isokinetic extension.
Strength measures were corrected for gravity by dividing the max-
imum torque by BMI. VPT and quadriceps muscle strength were
categorized into sex-speciﬁc groups based on 1 SD of the mean of the
sample.
At all visits, participants were asked about symptoms and frequency of
knee instability in the past 3 months. Knee “buckling” was deﬁned
according to a question that asked if and how many times the partic-
ipant noted their knee “giving way”. Knee “slipping” was deﬁned
according to a question that asked if and howmany times the knee “felt
like it was shifting, slipping, or going to give way but didn’t actually do
so”. Knee instability was deﬁned as the occurrence of either symptom.
Incident instability was deﬁned as someone who answered “no” to
experiencing either symptom at the 60 month visit but answered “yes”
to one or both at the 72 or 84 month visit. Worsening of instability was
deﬁned as an increase in frequency using the 3-level variable with 0-1
times, 2–5 times, and >5 episodes over 3 months. Subjects with >5
times instability at 60 M were excluded. An increase in one level or
more of frequency was considered worsening. A person-based analyses
using Poisson regression with robust error variance to estimate adjus-
ted relative risk for the association of VPT and muscle strength with
knee instability incidence and progressionwas performed. We adjusted
in analyses for age, sex, BMI, race, clinic site, KL grade andWOMAC knee
pain as well as for each predictor (muscle strength and VPT).Results:We evaluated 2212 participants (60% women, mean [SD] age¼
68 [8] years, and mean [SD] BMI ¼ 31 [6]). 17% of participants reported
buckling, 29% reported slipping and 37% reported instability (buckling
and/or slipping) in the past 3 months at the 60-month visit. Over the
follow-up period, 32% developed incident instability, and 20% had
incident buckling. Similarly, 11% had worsening of instability, and 21%
had worsening of buckling. Quadriceps weakness and impaired
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S378vibratory sense were each associated with the risk of incident knee
instability, and impaired vibratory sense predicted worsening of both
outcomes (see Table).
Conclusions: In this large cohort of participants, impaired vibratory
sense and quadriceps weakness were each associated with a range of
knee instability outcomes. Thus, vibratory sense and muscle strength
may be important risk factors for knee instability in persons with or at
risk for knee OA.Table.
Adjusted RR (95%CI)** p value Adjusted RR (95%CI)** p value
Knee instability (buckling and/or slipping) incidence Buckling incidence
Vibratory sense at tibial tuberosity Lower 1.21 (0.98, 1.50) 0.084 Lower 1.05 (0.79, 1.40) 0.725
Reference 1 Reference 1
Greater 0.80 (0.57, 1.12) 0.194 Greater 0.68 (0.47, 1.00) 0.049
p for trend 0.024 p for trend 0.213
Quadriceps muscle strength Lower 1.14 (0.92, 1.41) 0.224 Lower 1.33 (1.03, 1.73) 0.030
Reference 1 0.90 (0.64, 1.26) Reference 1
Greater 0.60 (0.44, 0.84) 0.003 Greater 0.90 (0.64, 1.26) 0.537
p for trend <0.001 p for trend 0.028
Worsening knee instability (buckling and/or slipping) Worsening Buckling
Vibratory sense at tibial tuberosity Lower 1.29 (0.87, 1.93) 0.210 Lower 1.00 (0.77, 1.29) 0.979
Reference 1 Reference 1
Greater 0.42 (0.20, 0.88) 0.021 Greater 0.67 (0.47, 0.94) 0.020
p for trend 0.021 p for trend 0.020
Quadriceps muscle strength Lower 1.13 (0.73, 1.75) 0.573 Lower 1.18 (0.93, 1.51) 0.175
Reference 1 Reference 1
Greater 0.76 (0.43, 1.37) 0.363 Greater 0.89 (0.65, 1.22) 0.474
p for trend 0.189 p for trend 0.071
**adjusted for all covariates.670
END-STAGE KNEE OSTEOARTHRITIS IS INDEPENDENTLY ASSOCIATED
WITH A HIGHER PREVALENCE OF MEDICAL COMORBIDITIES
MARKED BY SYSTEMIC INFLAMMATION WHEN COMPARED TO
END-STAGE HIP OSTEOARTHRITIS
M.G. Zywiel, A.V. Perruccio, T. Jackson, R. Gandhi , Arthritis Program,
University Health Network; Univ. of Toronto, Toronto, ON, Canada
Purpose: Osteoarthritis (OA) of the knee has been reported to be
associated with a distinct pathogenesis and clinical proﬁle when com-
pared to OA of the hip. Furthermore, some authors have postulated that
knee OA in particular is marked by low-grade systemic inﬂammation.
However, it is unclear whether this is additionally associated with dif-
ferences in the prevalence of other medical comorbidities that have
been reported to be associated with a low-grade systemic inﬂammatory
state. Thus, the purpose of the present study was to assess whether
individuals with end-stage knee OA are more likely to have medical
comorbidities marked by systemic inﬂammation as compared to those
with end-stage hip OA.
Methods: All patients who underwent primary total knee (TKA) or hip
arthroplasty (THA) for a diagnosis of OAwere extracted from the 2010 to
2012 American College of Surgeons National Surgical Quality
Improvement Project databases. Combined, these databases include
preoperative risk factor and 30 day postoperative morbidity data from
374 clinical sites in North America, abstracted by trained reviewers. The
study cohort encompassed 54,022 cases, including 33,906 of knee OA
and 20,116 of hip OA. Patient data extracted included age, gender, and
body mass index (BMI) stratiﬁed by World Health Organization (WHO)
class. Comorbidities evaluated included hypertension requiring medi-
cation, diabetes, and metabolic syndrome (deﬁned as BMI of 30 kg/m2
or greater as well as the presence of hypertension and diabetes).
Additionally, smoking status within one year of surgery and chronic
systemic steroid use within 30 days of surgery were abstracted.
Descriptive statistics were obtained. Bivariate analyses were performed
using the chi-square statistic for categorical variables, and the Student’s
t-test for continuous variables. Logistic regression analysis was per-
formed to determine whether the odds of the presence of the comor-
bidities of interest differed between the knee and hip groups, adjusted
for covariates.
Results: Knee OA patients were signiﬁcantly older (mean age 67.1 vs
65.7 years; p < 0.001), had a higher prevalence of obesity (61.4% vs
44.6%; p < 0.001), and encompassed a greater proportion of women(62.7% vs 56.4%; p < 0.001) compared to hip OA patients. A signiﬁcantly
greater proportion of knee OA patients were being treated for hyper-
tension (66.8% vs 58.2%; p < 0.001), had diabetes (17.7% vs 8.8%; p <
0.001), and met criteria for metabolic syndrome (3.5% vs 1.7%; p <
0.001). Controlling for age, gender, class of obesity, smoking, and
chronic systemic steroid use, knee OA patients had signiﬁcantly greater
odds of a diagnosis of hypertension (OR 1.11; 95% CI [1.06–1.16]) and
diabetes (OR 1.35; 95% CI [1.27–1.42]), and of meeting the criteria for
metabolic syndrome (OR 1.35; 95% CI [1.18–1.54]).Conclusions: While arthroplasty patients with knee OA are marked by
differences in demographic proﬁle compared to those with hip OA, the
results of the present study demonstrate that these variations alone fail
to explain observed discrepancies in the prevalence of associated
patient comorbidities. Even when controlled for demographic proﬁle,
smoking, and chronic steroid use, patients with knee OA continued to
have signiﬁcantly greater odds of an associated diagnosis of hyper-
tension, diabetes, or the presence of metabolic syndrome. These ﬁnd-
ings further support the notion that knee OA is marked by unique
associations with systemic disease. Further work is needed to better
understand the nature of these associations, as well as to investigate
potential interactions between these conditions, each of which has
been reported to be independently associated with a systemic inﬂam-
matory state.
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OSTEOARTHRITIS-RELATED DISABILITY AND RISK FOR SERIOUS
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Purpose: Functional limitations from hand, hip and knee osteoarthritis
(OA) may impact the ability of diabetes patients to manage their dia-
betes. Thus, we examined the impact of OA symptom severity on dia-
betes-related complications in persons affected by both OA and
diabetes.
Methods: This retrospective cohort study used data from a population
cohort with symptomatic hip and knee OA that was recruited from
1996–98 through a screening survey of 100% of the population aged
55þ years in two Ontario regions (n ¼ 2,225 had OA conﬁrmed on
examination and x-ray). The baseline survey assessed: socio-demo-
graphics; smoking; self-reported height, weight and NSAID use;
comorbidity (including physician diagnosis and treatment in the past
year for high blood pressure, diabetes, and heart problems); and mental
health status (SF-36 mental health subscale). OA functional limitations
were assessed using the Western Ontario McMaster Universities OA
Index, WOMAC, physical function subscale, and the Health Assessment
Questionnaire grip subscale and walking subscale (both 0–3; higher
